Table 1 Reported population-based prevalence of gonorrhoea in women and men by WHO region and country
From: Gonorrhoea: a systematic review of prevalence reporting globally
WHO region | Country | No. of data points | Reference | Years reported | Study populationa | Study setting | Sampling | No. tested | Reported prevalence | Standardized prevalence |
|---|---|---|---|---|---|---|---|---|---|---|
WOMEN | ||||||||||
 Africa | Benin | 1 | Behanzin et al. [13] | 2008 | Community, Women | Households | Cluster random | 1241 | 0.60% | 0.62% |
Malawi | 1 | Paz-Soldan et al. [14] | 2000 | Community, Women | Households | Multistage cluster random | 758 | 3.60% | 4.13% | |
South Africa | 1 | Francis et al. [15] | 2016–2017 | Community, Women | Annual household survey | Stratified random | 259 | 1.80% | 1.14% | |
 Americas (excluding high-income North America) | Brazil | 1 | de Lima et al. [16] | 2007–2009 | Community, Sexually active, Women | Household-based recruitment | Simple random | 574 | 0.70% | 0.72% |
Perub | 1 | Carcamo et al. [17] | 2002 | Community, Women | Household survey | Cluster random | 6439 | 0.10% | 0.00% | |
 Europe | UKb | 1 | Sonnenberg et al. [18] | 2010–2012 | Community, Women | Natsal-3 respondents | Probability | 2665 | <0.1% | 0.10% |
 High-income North America | USAb | 1 | Torrone et al. [19] | 1999–2008 | Community, Women | Household surveys | Multistage probability | ·· | 0.34%c | 0.37%c |
 Western Pacific | China | 2 | Huai et al. [20] | 2016 | Community, Women | General population | Multistage probability | 3581 | 0.14% | 0.14% |
| Â | Â | Luo et al. [21] | 2017 | Community, Women | Community-based recruitment | Probability | 9207 | 0.17% | 0.18% | |
New Caledonia (France)b | 1 | Corsenac et al. [22] | 2012 | Community, Women | Primary care and public dispensaries | Multistage random | 376 | 3.47% | 3.99% | |
MEN | ||||||||||
 Africa | Benin | 1 | Behanzin et al. [13] | 2008 | Community, Sexually active, Men | Households | Cluster random | 1040 | 0.30% | 0.23% |
Malawi | 1 | Paz-Soldan et al. [14] | 2000 | Clinic attendees, Men | Households | Cluster random | 469 | 6.20% | 7.94% | |
South Africa | 1 | Francis et al. [15] | 2016–2017 | Community, Men | Annual household survey | Stratified random | 188 | 1.50% | 1.82% | |
 Americas (excluding high-income North America) | Perub | 1 | Carcamo et al. [17] | 2002 | Community, Men | Household survey | Cluster random | 7486 | 0.12% | 0.02% |
 Europe | UKb | 1 | Sonnenberg et al. [18] | 2010–2012 | Community, Men | Natsal-3 respondents | Probability | 1885 | <0.1% | <0.1% |
 High-income North America | USAb | 1 | Torrone et al. [19] | 1999–2008 | Community, men | Household surveys | Multistage probability | ·· | ·· (0.27% for men and women combined)c | ·· (0.27% for men and women combined)c |
 Western Pacific | China | 1 | Huai et al. [20] | 2016 | Community, Men | General population | Multistage probability | 3622 | 0.03% | 0.00% |
New Caledonia (France)b | 1 | Corsenac et al. [22] | 2012 | Clinic attendees, Men | Primary care and public dispensaries | Multistage random | 232 | 3.45% | 4.36% | |